ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.66
0.05%
US Tech 100
20,803.20
-1.80%
S&P 500
5,943.07
-1.57%
US Dollar vs CAD
1.44235
0.09%
Bitcoin
93,835.35
-1.93%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Vivoryon Therapeut (05Y) Share Price

Vivoryon Therapeut

Vivoryon Therapeut (05Y)

TG
2.03
0.062
( 3.15% )
Updated: 11:04:22
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
2.03
Bid
1.982
Ask
2.03
Volume
50,759
1.94 Day's Range 2.075
0.00 52 Week Range 0.00
Market Cap
52.916M
Previous Close
1.968
Open
1.998
Last Trade
1
@
2.0299999
Last Trade Time
11:03:46
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
26,066,808
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-3.62M
Net Profit
-28.34M

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
-
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 05Y. The last closing price for Vivoryon Therapeut was 1.97 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.00 € to 0.00 €.

Vivoryon Therapeut currently has 26,066,808 shares outstanding. The market capitalization of Vivoryon Therapeut is 51.30 € million.

Ask ADVFN Intelligence (AI)

05Y Latest News

More News

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

December 09 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

December 04 2024
UK Regulatory

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

October 26 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

October 11 2024
UK Regulatory

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

October 01 2024
UK Regulatory

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

September 12 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

September 05 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

September 05 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

July 18 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

July 09 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

05Y - Frequently Asked Questions (FAQ)

What is the current Vivoryon Therapeut share price?
The current share price of Vivoryon Therapeut is 2.03 €
How many Vivoryon Therapeut shares are in issue?
Vivoryon Therapeut has 26,066,808 shares in issue
What is the market cap of Vivoryon Therapeut?
The market capitalisation of Vivoryon Therapeut is EUR 51.3M
What is the 1 year trading range for Vivoryon Therapeut share price?
Vivoryon Therapeut has traded in the range of 0.00 € to 0.00 € during the past year
What is the reporting currency for Vivoryon Therapeut?
Vivoryon Therapeut reports financial results in EUR
What is the latest annual turnover for Vivoryon Therapeut?
The latest annual turnover of Vivoryon Therapeut is EUR -3.62M
What is the latest annual profit for Vivoryon Therapeut?
The latest annual profit of Vivoryon Therapeut is EUR -28.34M
What is the registered address of Vivoryon Therapeut?
The registered address for Vivoryon Therapeut is WEINBERGWEG 22, HALLE, 06120
What is the Vivoryon Therapeut website address?
The website address for Vivoryon Therapeut is www.vivoryon.com
Which industry sector does Vivoryon Therapeut operate in?
Vivoryon Therapeut operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
Z4UreAlpha Tech Corp
2.515 €
(107.68%)
7.33k
PU11Social Chain AG
0.0238 €
(105.17%)
811.13k
2WOWide Open Agriculture Ltd
0.01 €
(100.00%)
18k
510Graphex Group Limited
0.366 €
(92.63%)
15k
M000Vertical Aerospace Ltd
13.80 €
(91.67%)
8.01k
E3O1Nexoptic Technology Corp
0.009 €
(-51.35%)
10.62k
1RR1Rokmaster Resources Corp
0.006 €
(-50.00%)
19k
7CCCheckCap Ltd
1.14 €
(-47.22%)
265
AWY0Percheron Therapeutics Ltd
0.003 €
(-45.45%)
15k
7KOCullinan Metals Corp
0.0068 €
(-42.37%)
72k
PF8European Lithium Limited
0.024 €
(18.81%)
9.04M
D7GNel ASA
0.2413 €
(-3.71%)
4.64M
RQ0DWave Quantum Inc
9.664 €
(23.45%)
2.63M
34Q0Quantum eMotion Inc
0.61 €
(70.39%)
2.57M
M11First Graphene Limited
0.0164 €
(-9.89%)
2.35M

Discussion

View Full Feed
jbsliverer jbsliverer 3 minutes ago
AI might be used to save them, or maybe just to put everybody out of their misery.


Godfather of AI’ raises odds of the technology wiping out humanity over next 30 years
https://www.theguardian.com/technology/2024/dec/27/godfather-of-ai-raises-odds-of-the-technology-wip
AugustaFriends AugustaFriends 3 minutes ago
$QSI near HOD watch for $4.11 BOOM Orions
QSI
Telling you there’s a chance Telling you there’s a chance 3 minutes ago
Proto “the gauntlet was put down with the issuance of the new CEO and President Incentive Options being FULLY VESTED in 6 months or June of 2025,”

That’s not good business! What are you posting? I guess you guys can delete all my posts but when KCCO says Poet is the real deal. No prob
LWLG
I-Glow I-Glow 4 minutes ago
The OTC is for trading not investing - Park won't be around in 2 to 5 years.

Same half dozen or so 🤡’s going try the same dump game nonsense tomorrow morning, boring. I am not Fallin’ for it. Holding long and strong, in it to win it. I am focused on 2 and 5 years charts that a
SPZI
iamthe walrus iamthe walrus 4 minutes ago
Coretec won the vote and according to filings after the vote received their Director positions as inside or outside directors. according to filings Seon Kim was given the CEO role and the temporary CEO also was kept on as CEO .The others became inside and outside Directors . I made several posts co
CRTG
dig4gold dig4gold 4 minutes ago
We just need better communication and some real updates from the incoming company along with a dedicated pr team and this will run hard.
CGAC
manibiotech manibiotech 4 minutes ago
I have raised the same question many times and been called basher . 
Only time she invested money was when she gave loan and took 10% interest from cash strapped company (her own company) and demanded loan payback in few months . 
Moreover keep taking cash from NW to advent 
NWBO
PonkenPlonken PonkenPlonken 4 minutes ago
VOR 1.12 nHOD
VOR
KISSINGER KISSINGER 5 minutes ago
Yes and we are all looking for world peace LOL. She cannot hold minor gains. Southbound soon. Put in your stops
ZENA
mascale mascale 5 minutes ago
The waterchaser brand, supportive of nothing it can corroborate--is noted to support a Jack_Herer post with basis in nothing it can corroborate. What may have appeaed untenable then picked up supporti as of 12/9--in filings at OTCMG. Beyond the original management from Qatar--in league with know
HIRU
work-n-hard work-n-hard 5 minutes ago
lol I'm hoping I can Houdini my way out of the 3's & 4's I bought. Sure didn't expect the 2's to begin with.
This might end up being a loss for me, but I can't complain.
That is usually what it takes for me to quit flipping one. (At myself....SMH)
TSOI
Tiger Money Tiger Money 5 minutes ago
That $50 million is already done most likely over the last two days as we have had about $200-300 million in dollar volume 
KULR
Golden Cross Golden Cross 5 minutes ago
$GRLF $ILST $GVSI Three Sub Plays to add to your watch list. I think these three will be runners in the new year.
GRLF GVSI ILST
tw0122 tw0122 6 minutes ago
No just GTI running some more 
GTI
vlispxpert vlispxpert 6 minutes ago
GTI niiiiice!
GTI
Golden Cross Golden Cross 6 minutes ago
$GRLF $ILST $GVSI Three Sub Plays to add to your watch list. I think these three will be runners in the new year.
GRLF GVSI ILST
gapole gapole 6 minutes ago
you make sure your tin cup is full of pencils to sell
QMCO
Stinger2014 Stinger2014 6 minutes ago
Powder spent! Now we wait some more!! 👍
CGAC
stock king 1 stock king 1 6 minutes ago
This pile of chit crash and burn 🔥
VXIT
JMCK6193 JMCK6193 6 minutes ago
Hopefully soon the thief will be in prison 
VXIT
vlispxpert vlispxpert 6 minutes ago
What's that for, A S S T?
tw0122 tw0122 7 minutes ago
GTI $1s lol
GTI
koolmc koolmc 7 minutes ago
np 👍️
EEGI
janice shell janice shell 7 minutes ago
I disagree. The stock and company are going under. At best, it's another of those "bankruptcy plays" that people who don't know what they're doing fall for. At worst, it's a pure bot play designed to take advantage of holiday trading, when the serious players are all on vacation. Not that serious pl
QueenVic QueenVic 7 minutes ago
That's the same routine with the twins: up/down.... I don't know if you paid attention to FMMA board lately? Some folks are just being overreacting and can't take the heat with the twins because they're volatile...
Like, duh it's OTC and conservatorship.

... I just can't wait

Your Recent History

TG
05Y
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads